Metabolomics diagnostic approach to mustard airway diseases: a preliminary study
- سال انتشار: 1397
- محل انتشار: مجله علوم پایه پزشکی ایران، دوره: 21، شماره: 1
- کد COI اختصاصی: JR_IJBMS-21-1_010
- زبان مقاله: انگلیسی
- تعداد مشاهده: 229
نویسندگان
BiBi Fatemeh Nobakht Mothlagh Ghoochani
Department of Basic Medical Sciences, Neyshabur University of Medical Sciences, Neyshabur, Iran
Pulmonary Department, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran
Department of Basic Sciences, Faculty of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Proteomics Research Center, Faculty of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Chronic Kidney Disease Research Center, Labbafinejad Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Department of Chemistry, Faculty of Sciences, Tarbiat Modares University, Tehran, Iran
Physiotherapy Research Center, School of Rehabilitation, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Department of Chemistry, Sharif University of Technology, Tehran, Iran
Department of Chemistry, Faculty of Science, University of Tehran, Tehran, Iran
چکیده
Objective(s): This study aims to evaluate combined proton nuclear magnetic resonance (۱H NMR) spectroscopy and gas chromatography-mass spectrometry (GC-MS) metabolic profiling approaches, for discriminating between mustard airway diseases (MADs) and healthy controls and for providing biochemical information on this disease. Materials and Methods: In the present study, analysis of serum samples collected from ۱۷ MAD subjects and ۱۲ healthy controls was performed using NMR. Of these subjects, ۱۴ (۸ patients and ۶ controls) were analyzed by GC-MS. Then, their spectral profiles were subjected to principal component analysis (PCA) and orthogonal partial least squares regression discriminant analysis (OPLS-DA). Results: A panel of twenty eight metabolite biomarkers was generated for MADs, sixteen NMR-derived metabolites (۳-methyl-۲-oxovaleric acid, ۳-hydroxyisobutyrate, lactic acid, lysine, glutamic acid, proline, hydroxyproline, dimethylamine, creatine, citrulline, choline, acetic acid, acetoacetate, cholesterol, alanine, and lipid (mainly VLDL)) and twelve GC-MS-derived metabolites (threonine, phenylalanine, citric acid, myristic acid, pentadecanoic acid, tyrosine, arachidonic acid, lactic acid, propionic acid, ۳-hydroxybutyric acid, linoleic acid, and oleic acid). This composite biomarker panel could effectively discriminate MAD subjects from healthy controls, achieving an area under receiver operating characteristic curve (AUC) values of ۱ and ۰.۷۹ for NMR and GC-MS, respectively. Conclusion: In the present study, a robust panel of twenty-eight biomarkers for detecting MADs was established. This panel is involved in three metabolic pathways including aminoacyl-tRNA biosynthesis, arginine, and proline metabolism, and synthesis and degradation of ketone bodies, and could differentiate MAD subjects from healthy controls with a higher accuracy.کلیدواژه ها
GC-MS, Metabolomics, Multivariate analysis, NMR spectroscopy, Sulfur mustardاطلاعات بیشتر در مورد COI
COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.
کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.